Parkside Financial Bank & Trust’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-65
| Closed | -$6.6K | – | 2722 |
|
|
2025
Q4 | $6.6K | Buy |
65
+9
| +16% | +$723 | ﹤0.01% | 1719 |
|
|
2025
Q3 | $3.06K | Buy |
56
+1
| +2% | +$50 | ﹤0.01% | 1876 |
|
|
2025
Q2 | $2.92K | Buy |
55
+14
| +34% | +$711 | ﹤0.01% | 1874 |
|
|
2025
Q1 | $1.78K | Sell |
41
-6
| -13% | -$304 | ﹤0.01% | 1918 |
|
|
2024
Q4 | $2.64K | Sell |
47
-201
| -81% | -$12.5K | ﹤0.01% | 1579 |
|
|
2024
Q3 | $16.9K | Buy |
248
+171
| +222% | +$9.65K | ﹤0.01% | 1100 |
|
|
2024
Q2 | $3.25K | Buy |
77
+1
| +1% | +$55 | ﹤0.01% | 1462 |
|
|
2024
Q1 | $5.25K | Buy |
76
+18
| +31% | +$1.14K | ﹤0.01% | 1332 |
|
|
2023
Q4 | $4.29K | Sell |
58
-154
| -73% | -$10.1K | ﹤0.01% | 1340 |
|
|
2023
Q3 | $14.5K | Sell |
212
-111
| -34% | -$9.42K | ﹤0.01% | 1009 |
|
|
2023
Q2 | $30.3K | Sell |
323
-173
| -35% | -$13.5K | 0.01% | 767 |
|
|
2023
Q1 | $33.6K | Buy |
496
+134
| +37% | +$8.61K | 0.01% | 716 |
|
|
2022
Q4 | $17.9K | Buy |
362
+336
| +1,292% | +$13.7K | 0.01% | 880 |
|
|
2022
Q3 | $1K | Sell |
26
-86
| -77% | -$3.55K | ﹤0.01% | 1671 |
|
|
2022
Q2 | $4K | Buy |
112
+101
| +918% | +$5.4K | ﹤0.01% | 1318 |
|
|
2022
Q1 | $1K | Sell |
11
-62
| -85% | -$4.53K | ﹤0.01% | 1712 |
|
|
2021
Q4 | $6K | Sell |
73
-20
| -22% | -$1.76K | ﹤0.01% | 1230 |
|
|
2021
Q3 | $9K | Sell |
93
-159
| -63% | -$16.8K | ﹤0.01% | 992 |
|
|
2021
Q2 | $31K | Buy |
252
+14
| +6% | +$1.67K | 0.01% | 640 |
|
|
2021
Q1 | $32K | Buy |
238
+85
| +56% | +$11.6K | 0.01% | 618 |
|
|
2020
Q4 | $21K | Buy |
153
+145
| +1,813% | +$17.5K | 0.01% | 708 |
|
|
2020
Q3 | $1K | Sell |
8
-122
| -94% | -$10.5K | ﹤0.01% | 1323 |
|
|
2020
Q2 | $11K | Buy |
130
+27
| +26% | +$2.16K | ﹤0.01% | 792 |
|
|
2020
Q1 | $6K | Sell |
103
-134
| -57% | -$10.9K | ﹤0.01% | 826 |
|
|
2019
Q4 | $22K | Buy |
237
+45
| +23% | +$3.96K | 0.01% | 627 |
|
|
2019
Q3 | $17K | Buy |
192
+10
| +5% | +$1.14K | 0.01% | 664 |
|
|
2019
Q2 | $21K | Hold |
182
| – | – | 0.01% | 621 |
|
|
2019
Q1 | $16K | Hold |
182
| – | – | 0.01% | 670 |
|
|
2018
Q4 | $11K | Buy |
182
+41
| +29% | +$2.81K | ﹤0.01% | 717 |
|
|
2018
Q3 | $11K | Buy |
+141
| New | +$9.2K | ﹤0.01% | 744 |
|
|
2018
Q2 | – | Sell |
-123
| Closed | -$5K | – | 1551 |
|
|
2018
Q1 | $5K | Buy |
123
+68
| +124% | +$3.32K | ﹤0.01% | 844 |
|
|
2017
Q4 | $3K | Sell |
55
-36
| -40% | -$1.92K | ﹤0.01% | 918 |
|
|
2017
Q3 | $4K | Hold |
91
| – | – | ﹤0.01% | 875 |
|
|
2017
Q2 | $3K | Buy |
+91
| New | +$2.81K | ﹤0.01% | 929 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Parkside Financial Bank & Trust's EXAS Position: Q1 2026 in Review
Parkside Financial Bank & Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 65 shares — an estimated $6.6K sold.
Parkside Financial Bank & Trust first reported a position in EXAS in Q2 2017 and held it in 34 quarters. The position peaked at $33.6K in Q1 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Parkside Financial Bank & Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 65 Exact Sciences shares in Q1 2026, an estimated $6.6K.
- Parkside Financial Bank & Trust first reported a position in Exact Sciences in Q2 2017 and held it in 34 quarters.
- Parkside Financial Bank & Trust's Exact Sciences position peaked at $33.6K in Q1 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.